| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Okt―17 |
Biochemical monitoring of SARS-CoV-2 VLP production stages using MIR spectroscopy and chemometrics |
Felipe Moura Dias, Thaissa Consoni Bernardino, Luis Giovani Oliveira Guardalini, Jean Lucas Tanaka, Jaci Leme, Ana Paula Peinado, et al. (+3) Wagner Quintilio, Soraia Attie Calil Jorge, Eutimio Gustavo Fernández Núñez |
| 2 |
[GO] |
2024―Aug―30 |
Scalable bioprocess for the high-yield production of SARS-CoV-2 trimeric spike protein-based immunogen (IMT-CVAX) using suspension CHO cells |
Sneha Singh, B. Vikram Kumar, Pranaya M. Mishra, Geetika Verma, Sahil Kumar, Suvechchha Pandit, et al. (+5) Reetesh Kumar, Rajesh P. Ringe, Shashank Tripathi, Nimesh Gupta, Ravi P.N. Mishra |
| 3 |
[GO] |
2023―Mrz―25 |
Baculovirus-expressed self-assembling SARS-CoV-2 nanoparticle vaccines targeting the S protein induce protective immunity in mice |
Xingjian Liu, Haozhi Song, Jianmin Jiang, Xintao Gao, Yongzhu Yi, Yuting Shang, et al. (+5) Jialei Li, Dan Li, Zhen Zeng, Yinü Li, Zhifang Zhang |
| 4 |
[GO] |
2023―Mrz―17 |
Process Development of a SARS-CoV-2 Nanoparticle Vaccine |
Diandra Martinez-Cano, Rashmi Ravichandran, Huong Le, H. Edward Wong, Bharat Jagannathan, Erik J. Liu, et al. (+16) William Bailey, Jane Yang, Kelli Matthies, Hedieh Barkhordarian, Bhavana Shah, Nithya Srinivasan, Jun Zhang, Angel Hsu, Jette Wypych, Jennitte Stevens, Deirdre Murphy Piedmonte, Les P. Miranda, Lauren Carter, Michael Murphy, Neil P. King, Neil Soice |
| 5 |
[GO] |
2023―Feb―13 |
Cellulase production from disposed COVID-19 personal protective equipment (PPE) using cyclic fed-batch strategies |
Navnit Kumar Ramamoorthy, Revanth Babu Pallam, Sahadevan Renganathan, Vemuri Venkateswara Sarma |
| 6 |
[GO] |
2023―Jan―31 |
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update |
Vivek P Chavda, Rajashri Bezbaruah, Sheetal Dolia, Nirav Shah, Sachin Verma, Shrinivas Savale, Suma Ray |
| 7 |
[GO] |
2022―Dez―09 |
Lessons Learned from COVID-19 Pandemic: Vaccine Platform Is a Key Player |
Samira Hossaini Alhashemi, Fatemeh Ahmadi, Ali Dehshahri |
| 8 |
[GO] |
2022―Sep―27 |
Novel electrochemical biosensor key significance of smart intelligence (IoMT & IoHT) of COVID-19 virus control management |
Amogha G Paladhi, M Manohar, Kaushik Pal, Sugumari Vallinayagam, Azhagu Saravana Babu Packirisamy, Vajiha Aafrin Bashreer, et al. (+2) R Sai Nandhini, Kingsley Eghonghon Ukhurebor |
| 9 |
[GO] |
2022―Aug―10 |
Charge transport properties of SARS-CoV-2 Delta variant (B.1.617.2) |
Lijun He, Zhiyang Xie, Xing Long, Chaopeng Zhang, Chengyun He, Boyang Zhao, et al. (+2) Fei Qi, Nan Zhang |
| 10 |
[GO] |
2022―Apr―14 |
Clinical progress of therapeutics and vaccines: Rising hope against COVID-19 treatment |
Ravi Bandaru, Smruti Rekha Rout, Omkar Kamble, Sangram K. Samal, Bapi Gorain, Amirhossein Sahebkar, et al. (+3) Farhan J. Ahmed, Prashant Kesharwani, Rambabu Dandela |
| 11 |
[GO] |
2022―Feb―17 |
In silico investigations of heparin binding to SARS-CoV-2 variants with a focus at the RBD/ACE2 interface |
Nemat Ali, Rehan Khan, Abdullah F. AlAsmari, Vijay Kumar |
| 12 |
[GO] |
2021―Aug―17 |
Repurposing the inhibitors of COVID-19 key proteins through molecular docking approach |
Huda Ahmed Alghamdi, Syed Awais Attique, Wei Yan, Anam Arooj, Obaid Albulym, Daochen Zhu, et al. (+2) Muhammad Bilal, Muhammad Zohaib Nawaz |
| 13 |
[GO] |
2021―Aug―03 |
Artificial intelligence: Potential tool to subside SARS-CoV-2 pandemic |
Nishanth Gopinath |
| 14 |
[GO] |
2020―Dez―25 |
Rapid Determination of Remdesivir (SARS-CoV-2 Drug) in Human Plasma for Therapeutic Drug Monitoring in COVID-19-Patients |
Raghavendra Rao Pasupuleti, Pei-Chien Tsai, Vinoth Kumar Ponnusamy, Arivalagan Pugazhendhi |
| 15 |
[GO] |
2020―Aug―20 |
A systematic review on recent trends in transmission, diagnosis, prevention and imaging features of COVID-19 |
S. Manigandan, Ming-Tsang Wu, Vinoth Kumar Ponnusamy, Vinay B. Raghavendra, Arivalagan Pugazhendhi, Kathirvel Brindhadevi |
|
